Capital Investment Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Capital Investment Advisory Services’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.6K	Buy	312 +10	+3%	+$2.07K	﹤0.01%	819
2025 Q4	$62.3K	Buy	302 +121	+67%	+$24.2K	﹤0.01%	787
2025 Q3	$32.4K	Buy	181 +70	+63%	+$11.9K	﹤0.01%	840
2025 Q2	$17.9K	Sell	111 -242	-69%	-$38.5K	﹤0.01%	887
2025 Q1	$60.1K	Sell	353 -21	-6%	-$3.65K	0.01%	684
2024 Q4	$62.2K	Buy	374 +2	+0.5%	+$342	0.01%	629
2024 Q3	$63.9K	Hold	372	–	–	0.01%	647
2024 Q2	$57.2K	Hold	372	–	–	0.01%	643
2024 Q1	$57.2K	Sell	372 -286	-43%	-$43.6K	0.01%	637
2023 Q4	$104K	Sell	658 -282	-30%	-$40.5K	0.01%	577
2023 Q3	$138K	Hold	940	–	–	0.01%	519
2023 Q2	$144K	Buy	940 +35	+4%	+$5.46K	0.01%	499
2023 Q1	$140K	Hold	905	–	–	0.02%	500
2022 Q4	$139K	Buy	905 +566	+167%	+$83.5K	0.02%	504
2022 Q3	$45K	Hold	339	–	–	0.01%	581
2022 Q2	$46K	Hold	339	–	–	0.01%	599
2022 Q1	$51K	Buy	+339	New	+$50.1K	0.01%	623
2021 Q3	–	Sell	-349	Closed	-$60K	–	773
2021 Q2	$60K	Buy	+349	New	+$57.6K	0.01%	572
2021 Q1	–	Sell	-445	Closed	-$75K	–	740
2020 Q4	$75K	Buy	445 +285	+178%	+$46.2K	0.01%	483
2020 Q3	$25K	Buy	160 +150	+1,500%	+$24.5K	﹤0.01%	491
2020 Q2	$2K	Hold	10	–	–	﹤0.01%	542
2020 Q1	$1K	Hold	10	–	–	﹤0.01%	547
2019 Q4	$1K	Hold	10	–	–	﹤0.01%	537
2019 Q3	$1K	Buy	10 +3	+43%	+$399	﹤0.01%	1317
2019 Q2	$1K	Buy	7 +5	+250%	+$690	﹤0.01%	1332
2019 Q1	$0	Buy	+2	New	+$288	﹤0.01%	1223

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Capital Investment Advisory Services's FBT Position: Q1 2026 in Review

Capital Investment Advisory Services increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3.3% in Q1 2026, buying an estimated $2.07K and bringing the position to 312 shares worth $62.6K. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Capital Investment Advisory Services first reported a position in FBT in Q1 2019 and has held it in 26 quarters since. The position peaked at $144K in Q2 2023. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Capital Investment Advisory Services held 312 shares of First Trust NYSE Arca Biotechnology Index Fund worth $62.6K as of Q1 2026.
Capital Investment Advisory Services bought 10 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $2.07K.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Capital Investment Advisory Services's portfolio in Q1 2026, its #819 holding.
Capital Investment Advisory Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 26 quarters since.
Capital Investment Advisory Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $144K in Q2 2023.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Capital Investment Advisory Services's 13F filing for Q1 2026, filed 5 May 2026.